Angiotensin-converting inhibitors in patients with congestive heart failure: A class effect?
- 1 July 1991
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (1) , 106-108
- https://doi.org/10.1016/0002-9149(91)90720-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure studyThe American Journal of Cardiology, 1991
- Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial)The American Journal of Cardiology, 1990
- Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failureThe American Journal of Cardiology, 1990
- Pharmacology of angiotensin-converting enzyme inhibitors as a guide to their use in congestive heart failureThe American Journal of Cardiology, 1990
- Tissue renin-angiotensin systems in the heart and vasculature: Possible involvement in the cardiovascular actions of converting enzyme inhibitorsThe American Journal of Cardiology, 1990
- Interference of different ACE-inhibitors with the diuretic action of furosemide and hydrochlorothiazideJournal of Molecular Medicine, 1989
- Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart FailureJAMA, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983